Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now?
Neuromuscul Disord
.
2005 Jun;15(6):399-402.
doi: 10.1016/j.nmd.2005.03.003.
Epub 2005 Apr 18.
Authors
Steve D Wilton
,
Susan Fletcher
PMID:
15907285
DOI:
10.1016/j.nmd.2005.03.003
No abstract available
Publication types
Editorial
Review
MeSH terms
Genetic Therapy / methods*
Humans
Muscular Dystrophy, Duchenne / therapy*
Oligonucleotides, Antisense / therapeutic use*
Substances
Oligonucleotides, Antisense